Indraprastha Medical Corporation Ltd

₹ 373 0.28%

25 Aug - close price

delhi.apollohospitals.com BSE: 532150 NSE: INDRAMEDCO

About

Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. ^[1]

Key Points

JV of Apollo
IMCL is a JV between Apollo Hospital (22%) and the State Government of Delhi (26%), and has presence in the NCR with two facilities, a 718-bedded facility in Sarita Vihar (operational since 1996) and a 46-bedded facility in Noida (since 2006). ^[1]

Website BSE NSE

Market Cap ₹ 3,418 Cr.
Current Price ₹ 373
High / Low ₹ 641 / 342
Stock P/E 18.2
Book Value ₹ 80.8
Dividend Yield 1.07 %
ROCE 35.8 %
ROE 27.5 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company has delivered good profit growth of 132% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%
Company has been maintaining a healthy dividend payout of 26.3%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE 1000 BSE Hospitals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	307	317	306	315	348	350	325	334	365	381	372	365	406
	259	267	259	266	281	286	273	272	292	310	310	304	326
Operating Profit	47	50	47	48	67	64	52	61	73	71	62	61	80
OPM %	15%	16%	15%	15%	19%	18%	16%	18%	20%	19%	17%	17%	20%
	4	4	4	5	5	6	5	6	7	7	7	7	8
Interest	1	1	1	2	2	2	2	1	2	2	1	1	2
Depreciation	10	10	10	10	11	11	11	11	10	11	11	11	12
Profit before tax	40	44	41	42	60	57	45	55	68	66	56	55	75
Tax %	24%	25%	28%	25%	25%	26%	26%	26%	25%	25%	27%	24%	25%
	30	33	29	31	45	42	33	41	51	49	41	42	56
EPS in Rs	3.33	3.58	3.21	3.40	4.88	4.63	3.58	4.47	5.61	5.40	4.47	4.55	6.09
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	714	755	766	753	788	831	613	888	1,099	1,245	1,356	1,483	1,524
	630	675	686	678	706	743	572	768	947	1,050	1,112	1,216	1,250
Operating Profit	85	80	79	74	82	87	41	120	152	195	245	267	274
OPM %	12%	11%	10%	10%	10%	11%	7%	14%	14%	16%	18%	18%	18%
	1	1	-0	-1	-1	-0	-0	-3	9	16	22	29	30
Interest	8	7	8	9	7	6	3	3	4	4	6	6	6
Depreciation	28	35	31	31	30	33	33	35	39	40	44	44	45
Profit before tax	50	39	41	34	45	48	4	79	117	166	216	246	253
Tax %	34%	37%	36%	38%	36%	9%	46%	26%	26%	25%	26%	25%
	32	24	26	21	28	44	2	59	86	124	161	184	188
EPS in Rs	3.54	2.66	2.86	2.30	3.10	4.76	0.25	6.39	9.40	13.52	17.56	20.03	20.51
Dividend Payout %	51%	68%	63%	65%	52%	0%	0%	39%	32%	33%	26%	20%

Compounded Sales Growth
10 Years:	7%
5 Years:	19%
3 Years:	11%
TTM:	11%

Compounded Profit Growth
10 Years:	22%
5 Years:	132%
3 Years:	28%
TTM:	12%

Stock Price CAGR
10 Years:	21%
5 Years:	38%
3 Years:	31%
1 Year:	-18%

Return on Equity
10 Years:	21%
5 Years:	27%
3 Years:	29%
Last Year:	27%

Balance Sheet

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	92	92	92	92	92	92	92	92	92	92	92	92
Reserves	103	132	139	141	152	176	181	234	288	386	505	649
	50	52	67	66	21	4	3	5	2	34	33	37
	196	185	160	134	157	177	157	131	173	212	222	214
Total Liabilities	442	460	458	432	422	449	432	462	555	723	852	991
	286	301	296	294	280	303	283	277	275	347	328	365
CWIP	3	3	0	0	1	0	3	0	3	0	33	3
Investments	0	0	0	0	0	0	0	0	0	0	0	0
	153	157	163	138	141	146	145	185	278	376	491	624
Total Assets	442	460	458	432	422	449	432	462	555	723	852	991

Cash Flows

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	64	62	28	48	75	86	27	94	144	200	157	167
	-29	-33	-22	-30	-17	-40	-19	-74	-108	-158	-111	-178
	-35	-30	-5	-17	-44	-43	-3	-3	-26	-32	-46	-46
Net Cash Flow	-0	-0	-0	1	14	4	5	17	11	9	-0	-57
Free Cash Flow	35	29	5	17	58	46	6	65	100	131	120	108
CFO/OP	98%	104%	57%	82%	110%	113%	88%	95%	102%	127%	89%	88%

Ratios

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	40	41	47	41	35	35	40	18	23	17	20	28
Inventory Days												11
Days Payable												182
Cash Conversion Cycle	40	41	47	41	35	35	40	18	23	17	20	-144
Working Capital Days	-35	-22	-17	-7	-5	-10	-1	-2	-12	-24	-19	-4
ROCE %	23%	18%	17%	15%	19%	21%	3%	29%	34%	38%	39%	36%

Insights

In beta

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Revenue per Bed Day (ARPOB)
Rs.

xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx
x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx
xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx
xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx
xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx
xx	xx			xx	xx			xx	xx	xx
xxx	xxx			xxx	xxx			xxx	xxx	xxx
				xx	xx			xx	xx

Please log in to see hidden values.

Average Length of Stay (ALOS)
days

Discharges (Inpatient Volumes)
count

Out-patients (OPD Visits)
count

Revenue per Patient
Rs.

Bed Occupancy Rate
%

Total Operational Beds
beds

International Patients Share of Revenue
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%
	0.81%	0.95%	1.08%	1.70%	2.64%	2.88%	2.94%	2.73%	2.41%	2.72%	2.43%	2.77%
	6.71%	6.36%	4.91%	3.14%	3.19%	3.18%	3.56%	3.56%	3.51%	0.82%	0.87%	0.59%
	41.49%	41.69%	43.01%	44.14%	43.16%	42.91%	42.50%	42.74%	43.08%	45.43%	45.69%	45.65%
No. of Shareholders	47,865	51,448	54,158	55,103	64,671	69,697	70,491	70,211	70,914	71,225	72,980	75,098

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%	51.00%
	0.08%	0.04%	0.00%	0.00%	0.00%	0.14%	0.27%	1.08%	2.94%	2.43%	2.77%
	2.59%	0.35%	0.31%	0.13%	0.02%	0.02%	0.00%	4.91%	3.56%	0.87%	0.59%
	46.33%	48.61%	48.70%	48.87%	48.98%	48.84%	48.72%	43.01%	42.50%	45.69%	45.65%
No. of Shareholders	46,625	38,155	36,132	36,562	44,840	56,540	49,833	54,158	70,491	72,980	75,098

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings